Literature DB >> 18206176

Efficacy of a novel device for assessment of autonomic sensory function in the rat bladder.

Robert Abouassaly1, Guiming Liu, Yasuhiro Yamada, Osamu Ukimura, Firouz Daneshgari.   

Abstract

PURPOSE: We developed and tested the efficacy of an implantable bladder device which, when combined with the Neurometer, can be used to assess fiber specific afferent bladder sensation in the rat.
MATERIALS AND METHODS: We developed an implantable bladder device that applies selective nerve fiber stimuli (250 Hz for small myelinated Adelta fibers and 5 Hz for unmyelinated C fibers) to the bladder mucosa in the rat to determine bladder sensory perception threshold values. We performed 3 experiments in 55 female Sprague-Dawley rats to examine the effects of our device on voiding habits, assess the interobserver reliability of the sensory perception threshold and determine the effects of intravesical administration of resiniferatoxin (Sigma) and lidocaine on the sensory perception threshold.
RESULTS: Sensory perception threshold values obtained by 2 blinded, independent observers were not different from each other (p = 0.41). Sensory perception threshold values obtained at the 2 stimulation frequencies remained constant for at least 3 weeks after device implantation. A significant increase in sensory perception threshold values after resiniferatoxin instillation was noted at a stimulus frequency of 5 Hz (p = 0.02), whereas intravesical lidocaine led to an immediate increase in the sensory perception threshold at 250 and 5 Hz. Device implantation led to an early decreased voided volume and increased frequency of voids, although these parameters returned to normal after 4 days.
CONCLUSIONS: Assessment of bladder afferent sensation with our newly developed device is feasible in rats. It provides sensory perception thresholds that appear to be fiber-type selective for autonomic bladder afferent nerves.

Entities:  

Mesh:

Year:  2008        PMID: 18206176      PMCID: PMC4060431          DOI: 10.1016/j.juro.2007.10.027

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  20 in total

1.  Reliability and characteristics of current perception thresholds in the territory of the infraorbital and inferior alveolar nerves.

Authors:  H S Kim; H S Kho; Y K Kim; S W Lee; S C Chung
Journal:  J Orofac Pain       Date:  2000

2.  Age and gender differences in skin sensory threshold assessed by current perception in community-dwelling Japanese.

Authors:  K Takekuma; F Ando; N Niino; H Shimokata
Journal:  J Epidemiol       Date:  2000-04       Impact factor: 3.211

3.  Analysis of the afferent limb of the vesicovascular reflex using neurotoxins, resiniferatoxin and capsaicin.

Authors:  Y C Chuang; M O Fraser; Y Yu; J M Beckel; S Seki; Y Nakanishi; H Yokoyama; M B Chancellor; N Yoshimura; W C de Groat
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2001-10       Impact factor: 3.619

4.  Neurometer measurement of current stimulus threshold in rats.

Authors:  T Kiso; Y Nagakura; T Toya; N Matsumoto; S Tamura; H Ito; M Okada; T Yamaguchi
Journal:  J Pharmacol Exp Ther       Date:  2001-04       Impact factor: 4.030

5.  New screening device for assessment of peripheral neuropathy.

Authors:  J J Katims; E H Naviasky; L K Ng; M Rendell; M L Bleecker
Journal:  J Occup Med       Date:  1986-12

6.  Effect of intravesical Resiniferatoxin (RTX) on lower urinary tract symptoms, urodynamic parameters, and quality of life of patients with urodynamic increased bladder sensation.

Authors:  Apostolos Apostolidis; Gwendoline E Gonzales; Clare J Fowler
Journal:  Eur Urol       Date:  2006-05-04       Impact factor: 20.096

7.  Analgesic properties of the novel compound M43068 in rat models of acute and neuropathic pain.

Authors:  Yasushige Akada; Reiko Mori; Yutaka Kato; Fumiaki Yamasaki; Hidenori Mochizuki
Journal:  Eur J Pharmacol       Date:  2005-10-13       Impact factor: 4.432

8.  Role of C afferent fibers and monitoring of intravesical resiniferatoxin therapy for patients with idiopathic detrusor overactivity.

Authors:  Teruhiko Yokoyama; Kunihiro Nozaki; Osamu Fujita; Hiroyuki Nose; Miyabi Inoue; Hiromi Kumon
Journal:  J Urol       Date:  2004-08       Impact factor: 7.450

9.  Neuroselective current perception threshold evaluation of bladder mucosal sensory function.

Authors:  Osamu Ukimura; So Ushijima; Hisashi Honjo; Tsuyoshi Iwata; Kei Suzuki; Naoki Hirahara; Koji Okihara; Yoichi Mizutani; Akihiro Kawauchi; Tsuneharu Miki
Journal:  Eur Urol       Date:  2004-01       Impact factor: 20.096

10.  Quantitative and selective evaluation of differential sensory nerve block after transdermal lidocaine.

Authors:  Tetsuya Sakai; Shiro Tomiyasu; Hiroyuki Yamada; Takeshi Ono; Koji Sumikawa
Journal:  Anesth Analg       Date:  2004-01       Impact factor: 5.108

View more
  4 in total

1.  Assessment of bladder sensation in mice with a novel device.

Authors:  Fuat Bicer; Jin Young Kim; Andrew Horowitz; Firouz Daneshgari; Guiming Liu
Journal:  Urology       Date:  2014-06-21       Impact factor: 2.649

2.  Efficacy of neuroselective and site-specific nociceptive stimuli of rat bladder.

Authors:  Yasuhiro Yamada; Osamu Ukimura; Guiming Liu; Tsuneharu Miki; Firouz Daneshgari
Journal:  Urology       Date:  2011-12-02       Impact factor: 2.649

3.  Autoimmunity to uroplakin II causes cystitis in mice: a novel model of interstitial cystitis.

Authors:  Cengiz Z Altuntas; Firouz Daneshgari; Cagri Sakalar; Esen Goksoy; M Fatih Gulen; Michael Kavran; Jun Qin; Xiaoxia Li; Vincent K Tuohy
Journal:  Eur Urol       Date:  2011-06-29       Impact factor: 20.096

4.  Bladder hyperactivity and increased excitability of bladder afferent neurons associated with reduced expression of Kv1.4 alpha-subunit in rats with cystitis.

Authors:  Yukio Hayashi; Koichi Takimoto; Michael B Chancellor; Kristin A Erickson; Vickie L Erickson; Tsukasa Kirimoto; Koushi Nakano; William C de Groat; Naoki Yoshimura
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-03-11       Impact factor: 3.619

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.